Chromosomal microarray (CMA) a powerful test for diagnosing the genetic abnormalities causing some types of developmental delay and birth defects can be used in an evidence-based manner to provide important information for patient treatment, according to a pair of studies in the September issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health...
More...
More...